帕妥珠单抗
曲妥珠单抗
医学
内科学
结直肠癌
肿瘤科
队列
临床终点
癌症
帕尼单抗
胃肠病学
西妥昔单抗
临床试验
乳腺癌
作者
R. Gupta,Funda Meric‐Bernstam,Michael Rothe,Elizabeth Garrett‐Mayer,Pam K. Mangat,Stacy D. D’Andre,Eugene R. Ahn,Raegan O'Lone,Susan Halabi,Gina N. Grantham,Richard L. Schilsky
出处
期刊:JCO precision oncology
[Lippincott Williams & Wilkins]
日期:2022-10-01
卷期号:6 (6): e2200306-e2200306
被引量:59
摘要
Although P + T treatment does not appear to have antitumor activity in CRC with ERBB2/3 mutations, this combination has antitumor activity in patients with CRC with ERBB2 amplification and warrants further study.
科研通智能强力驱动
Strongly Powered by AbleSci AI